1995
DOI: 10.1046/j.1471-4159.1995.64020902.x
|View full text |Cite
|
Sign up to set email alerts
|

Myelin P0 Glycoprotein: Identification of the Site Phosphorylated In Vitro and In Vivo by Endogenous Protein Kinases

Abstract: Myelin membrane prepared from mouse sciatic nerve possesses both kinase and substrates to incorporate [32P]PO43− from [γ‐32P]ATP into protein constituents. Among these, P0 glycoprotein is the major phosphorylated species. To identify the phosphorylated sites, P0 protein was in vitro phosphorylated, purified, and cleaved by CNBr. Two 32P‐phosphopeptides were isolated by HPLC. The exact localization of the sequences around the phosphorylated sites was determined. The comparison with rat P0 sequence revealed, bes… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

1
13
0

Year Published

1996
1996
2020
2020

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 21 publications
(14 citation statements)
references
References 19 publications
(23 reference statements)
1
13
0
Order By: Relevance
“…Treatment of P0-expressing cells with calphostin C, a specific inhibitor of protein kinase C, also inhibits P0-mediated adhesion in a dose-dependent manner, whereas inhibition with pervanadate, an inhibitor of tyrosine phosphorylation, does not. Consistent with these data, PKC has been shown to phosphorylate P0 at these same serine residues in vitro and in vivo [77,78], whereas a termination at amino acid 204 results in a severe demyelinating neuropathy in patients [79]. In addition, we have demonstrated that several isoforms of PKC are dramatically upregulated in sciatic nerves of P0 knockout mice [76].…”
Section: Human Myelin Protein Zerosupporting
confidence: 83%
See 1 more Smart Citation
“…Treatment of P0-expressing cells with calphostin C, a specific inhibitor of protein kinase C, also inhibits P0-mediated adhesion in a dose-dependent manner, whereas inhibition with pervanadate, an inhibitor of tyrosine phosphorylation, does not. Consistent with these data, PKC has been shown to phosphorylate P0 at these same serine residues in vitro and in vivo [77,78], whereas a termination at amino acid 204 results in a severe demyelinating neuropathy in patients [79]. In addition, we have demonstrated that several isoforms of PKC are dramatically upregulated in sciatic nerves of P0 knockout mice [76].…”
Section: Human Myelin Protein Zerosupporting
confidence: 83%
“…Region B contains three serine residues at amino acids 197, 199, and 204 known to be phosphorylated on P0 in vivo [77,78], and we have identified a putative protein kinase C (PKC) binding sequence, RSTK, located between amino acids 198 and 201 [76]. Mutations of each of the serines, at 199 and 204 to alanine residues, inhibit P0-mediated cell-cell adhesion.…”
Section: Human Myelin Protein Zeromentioning
confidence: 99%
“…Known phosphorylation sites are labelled (P). The P-site in brackets is phosphorylated in mice but not conserved in humans [66]. The lines below the alignment denote the individual P0 domains.…”
Section: The Molecular Structure Of P0mentioning
confidence: 99%
“…P 0 undergoes extensive phosphorylation, most prominently on serine residues in the cytoplasmic region of the protein (Brunden and Poduslo, 1987 ; Agrawal and Agrawal, 1989 ; Suzuki et al, 1990 ; Hilmi et al, 1995). Recently, we showed that P 0 can also be phosphorylated on tyrosine when rat sciatic nerves are incubated in vitro in the presence of pervanadate, a potent phosphotyrosine phosphatase inhibitor, and obtained initial indications that P 0 tyrosine phosphorylation is greater in nerves from developing as compared with adult rats (Iyer et al, 1996).…”
mentioning
confidence: 99%